Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review
Achille Aveta, Simone Cilio, Roberto Contieri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10846-10846
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Prostate cancer epigenetics — from pathophysiology to clinical application
Vera Constâncio, João Lobo, José Pedro Sequeira, et al.
Nature Reviews Urology (2025)
Closed Access | Times Cited: 1
A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors
Savio Domenico Pandolfo, Clara Cerrato, Zhenjie Wu, et al.
Asian journal of urology (2023) Vol. 10, Iss. 4, pp. 390-406
Open Access | Times Cited: 26
Biomarkers for Prostate Cancer: From Diagnosis to Treatment
Jiayan Chen, Peiyan Wang, Mingzhu Liu, et al.
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3350-3350
Open Access | Times Cited: 23
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data
Anas Tresh, Francesco Del Giudice, Shufeng Li, et al.
BJUI Compass (2025) Vol. 6, Iss. 1
Open Access
A review of the carcinogenic potential of human papillomavirus (HPV) in urological cancers
Ehsan Zolfi, Farhood Khaleghi mehr, Nikoo Emtiazi, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer Metastasis and Its Association with High-Grade Gleason Scores: Implications for Diagnosis
Marian Cruz-Burgos, Sergio A. Cortés-Ramírez, Alberto Losada-García, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4148-4148
Open Access | Times Cited: 10
Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma
Gaetano Pezzicoli, F. Ciciriello, Vittoria Musci, et al.
Current Oncology (2023) Vol. 30, Iss. 10, pp. 9276-9290
Open Access | Times Cited: 10
Inhibition of proliferation, migration, and invasiveness of bladder cancer cells through SAPCD2 knockdown
Chong Shen, Jia‐Jun Yan, Yu Ren, et al.
Biocell (2024) Vol. 48, Iss. 1, pp. 97-109
Open Access | Times Cited: 3
The value of a panel of circulating microRNAs in screening prostate cancer
Chen Sun, Chong Lu, Xinji Li, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 686-698
Open Access | Times Cited: 3
ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment
Wen-Gu Pan, Xiaoli Liu, Shuang‐De Liu
Medicine (2024) Vol. 103, Iss. 14, pp. e37590-e37590
Open Access | Times Cited: 3
Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study
Jian Deng, ShengYuan Tu, Lin Li, et al.
Cancer Reports (2024) Vol. 7, Iss. 6
Open Access | Times Cited: 3
Evaluating the Urinary Exosome microRNA Profile of von Hippel Lindau Syndrome Patients with Clear Cell Renal Cell Carcinoma
Beatriz Walter-Rodriguez, Christopher J. Ricketts, W. Marston Linehan, et al.
Genes (2024) Vol. 15, Iss. 7, pp. 905-905
Open Access | Times Cited: 3
The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives
Francesco Ditonno, Antonio Franco, Celeste Manfredi, et al.
Medicina (2023) Vol. 59, Iss. 11, pp. 2033-2033
Open Access | Times Cited: 8
Relevance of HOTAIR rs920778 and rs12826786 Genetic Variants in Bladder Cancer Risk and Survival
Eduarda P. Martins, Joana Vieira de Castro, R. C. Fontes, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 434-434
Open Access | Times Cited: 2
Autophagy and circadian rhythms: interactions and clinical implications
TIANKAI DI, ZHIFEI ZHOU, FEN LIU, et al.
Biocell (2024) Vol. 48, Iss. 1, pp. 33-45
Open Access | Times Cited: 2
Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder Cancer
Yuan‐Hong Jiang, Yushu Liu, Yu‐Chung Wei, et al.
Diagnostics (2024) Vol. 14, Iss. 5, pp. 468-468
Open Access | Times Cited: 2
Expression of hsa-miRNA-15b, -99b, -181a and Their Relationship to Angiogenesis in Renal Cell Carcinoma
József Király, Erzsébet Szabó, Petra Fodor, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1441-1441
Open Access | Times Cited: 2
Screening Model for Bladder Cancer Early Detection With Serum miRNAs Based on Machine Learning: A Mixed‐Cohort Study Based on 16,189 Participants
Cong Lai, Zhensheng Hu, Jintao Hu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 20
Open Access | Times Cited: 2
Empowering Renal Cancer Management with AI and Digital Pathology: Pathology, Diagnostics and Prognosis
Елена Иванова, Alexey Fayzullin, Victor Grinin, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2875-2875
Open Access | Times Cited: 7
OncoUroMiR: Circulating miRNAs for Detection and Discrimination of the Main Urological Cancers Using a ddPCR-Based Approach
José Pedro Sequeira, Daniela Barros‐Silva, Patrícia Ferreira-Torre, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13890-13890
Open Access | Times Cited: 6
CYFIP2 serves as a prognostic biomarker and correlates with tumor immune microenvironment in human cancers
Qiliang Peng, Bixin Ren, Kedao Xin, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 6
Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer
Tzu-Yi Chen, Meredith Mihalopoulos, Laura Zuluaga, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14713-14713
Open Access | Times Cited: 6
Imaging-based adipose biomarkers for predicting clinical outcomes of cancer patients treated with immune checkpoint inhibitors: a systematic review
Xinyu Pei, Ye Xie, Yixuan Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Genomic Fabrics of the Excretory System’s Functional Pathways Remodeled in Clear Cell Renal Cell Carcinoma
Dumitru A. Iacobaş, Ehiguese Alade Obiomon, Sanda Iacobaş
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 12, pp. 9471-9499
Open Access | Times Cited: 6
PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development
Xinyuan Jiang, Zhiyong Xu, Sujing Jiang, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5042-5042
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top